J.W. Cole Advisors, Inc. Laboratory Corp Of America Holdings Transaction History

J.W. Cole Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$213.86 - $277.87 $175,151 - $227,575	-819 Closed	0 $0
Q1 2022 Jun 10, 2022	SELL	$259.82 - $298.18 $18.9 Million - $21.7 Million	-72,757 Reduced 98.89%	819 $216,000
Q1 2022 May 16, 2022	BUY	$259.82 - $298.18 $18.9 Million - $21.7 Million	72,756 Added 8872.68%	73,576 $143,000
Q4 2021 Jan 25, 2022	SELL	$271.6 - $314.21 $1,086 - $1,256	-4 Reduced 0.49%	820 $258,000
Q3 2021 Oct 26, 2021	SELL	$274.82 - $308.34 $14,840 - $16,650	-54 Reduced 6.15%	824 $232,000
Q2 2021 Aug 06, 2021	BUY	$251.87 - $278.14 $17,630 - $19,469	70 Added 8.66%	878 $242,000
Q1 2021 Apr 28, 2021	BUY	$204.88 - $255.03 $165,543 - $206,064	808 New	808 $206,000
Q4 2020 Feb 12, 2021	SELL	$186.91 - $214.42 $254,758 - $292,254	-1,363 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$167.03 - $201.3 $227,661 - $274,371	1,363 New	1,363 $257,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.